New Somatic Treatments for Child and Adolescent Depression

<p>First-line treatments for child and adolescent depression are cognitive–behavioral therapy, interpersonal therapy, fluoxetine, and escitalopram.<br /> What works besides routine first-line approaches? This episode discusses options to consider: Pharmaceuticals, nutraceuticals, somatomotor techniques (e.g., yoga), and neuromodulatory tools (e.g., ECT and TMS).</p> <p>Faculty: Jim Phelps, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC106"> <strong>Learn more about Premium Memberships here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-25-2578?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC106"> <strong>Earn 0.5 CMEs: Quick Take Vol. 25</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/new-somatic-treatments-for-child-and-adolescent-depression-part-1-2578-5017?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC106"> <strong>New Somatic Treatments for Child and Adolescent Depression (Part 1) </strong></a></li> </ul>